A COMPARISON OF NAPROXEN, INDOMETHACIN AND ASPIRIN IN OSTEO-ARTHRITIS

Google Scholar
  • 1 January 1980
    • journal article
    • research article
    • Vol. 7  (5) , 711-716
Abstract
Patients with osteoarthritis (OA) of the hip and knee received naproxen (750 mg/d [day]) or indomethacin (100 mg/d) in a 16 wk double-blind, crossover study, in which interspersion of repeated aspirin phases allowed a detrending adjustment which compensated for changes in baseline activity with time. Results of the 24 variables studied showed a favorable comparison of naproxen and indomethacin in reducing the symptoms of OA. Although most of the variables favored indomethacin, the differences were small and few were statistically significant. Considerably fewer side effects were seen with naproxen than with either indomethacin or aspirin, and naproxen was tolerated considerably better than indomethacin. Concurring with other studies, this trial showed that naproxen is a useful, well-tolerated drug for OA treatment.

This publication has 1 reference indexed in Scilit: